Navigation Links
Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
Date:7/30/2008

CAMBRIDGE, Mass., July 30 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,381,790 (the '790 patent) which protects the composition of matter for its PI-2301 peptide copolymer for the treatment of autoimmune diseases.

PI-2301 is currently in a Phase Ib multiple-ascending dose, double-blind, placebo-controlled randomized study in subjects with multiple sclerosis. Following establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009.

"This patent represents an important component in the development of our intellectual property in peptide copolymers, including PI-2301," stated Thomas P. Mathers, President and CEO of Peptimmune. "The '790 patent protects what we believe may become a very important therapy for the treatment of multiple sclerosis and other autoimmune diseases."

PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (Teva Pharmaceuticals). PI-2301 has been designed to be more efficacious and more convenient (weekly versus daily dosing) than Copaxone for the treatment of multiple sclerosis. PI-2301 works through immune modulation by enhancing the regulatory response of the immune system and thereby controlling the pathogenic autoimmune response observed in some diseases. In a Phase I single ascending dose, double blind placebo controlled randomized study, all doses of PI-2301 were safe and well tolerated, and no serious adverse events were observed. Pharmacodynamic assays demonstrated evidence of immune exposure consistent with the pharmacologic mechanism of action for PI-2301, and dose-dependent pharmacokinetics was observed.

PI-2301 has been optimized using Peptimmune's novel platform peptide chemistry and, in preclinical studies, has shown to be more potent and eff
'/>"/>

SOURCE Peptimmune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
2. Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
3. Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings
4. Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...NYVALE,Calif.,Nov.23/PRNewswire-FirstCall/--Accura...ldofradiosurgery,announcedtodaythatitsmanagementis...hcareConferenceinNewYorkonTuesday,December1,2009at...heJ.P.MorganSmall/MidCapConferenceinNewYorkonThurs...Alivewebcastofeachpresentationwillbeavailableonlin...
(Date:11/23/2009)...NVILLE,Pa.,Nov.23/PRNewswire-FirstCall/--WestPharm...atthecompany,sChiefOperatingOfficerMatthewT.Mullar...dentandformerChiefOperatingOfficerStevenA.Ellers,5...rdertoprovidemanagerialcontinuityandsupportfollowi... Westisaglobalmanufacturerofcomponentsandsystemsfo...
(Date:11/23/2009)...USANDOAKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amg...winningforBestOverallPipelineandforBestNewDrugforN.... ,, TheBestOverallPipelineawardwaspresentedtoA...ndmarketpotentialofthecompany,spipeline,aswellasit...othejudges,Amgen,spipelineisnotableforitsfocusonun...
Breaking Medicine Technology:Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6New clinical guidelines for exacerbations in cystic fibrosis 59956 1New clinical guidelines for exacerbations in cystic fibrosis 59956 2Synthetic cells shed biological insights while delivering battery power 10487 1Synthetic cells shed biological insights while delivering battery power 10487 2Sensing disasters from space 10483 1Sensing disasters from space 10483 2
(Date:11/24/2009)...2.0MillionAdBuyTargetingAK,AR,FL,IN,LA,ME,NE,NDand...ire/-- InthewakeoftheSenate,svoteonSaturdaytotake...iontodayannouncedanewadvertisingcampaigntargetingS...a,Louisiana,Maine,Nebraska,NorthDakota,andSouthDak...orMedicareandMedicaidServices(CMS)reportwhichconfi...
(Date:11/24/2009)...R,Maine,Nov.24/PRNewswire/--Thankstoaninnovativepr...eSystems(EMHS)andAnthemBlueCrossandBlueShieldinMai...isit"theirphysicianwithoutleavinghome. ,, Aspar...dmessagesandquestionsandcommunicateviaemailwiththe...dulingappointments,checkingontestresults,orrequest...
(Date:11/24/2009)...se is available in German . , International...th cancer is very good as far as survival is conce...ife, pain, and long-term consequences of the disea...s. This is the conclusion of the Institute for Qua...final report published on 16 October 2009. , Es...
(Date:11/24/2009)...ty reduced in those with undesirable blood levels,...althDay News) -- Abnormal cholesterol levels can s... new study has found. , U.S. researchers analyz...t, Lung, and Blood Institute,s Framingham Heart St... coronary heart disease at the start of the study....
(Date:11/24/2009)... New York personal injury attorney Dav...number of a personal injury attorney after a heavy...l Long Island backyard. , ...rk personal injury attorney David Perecman points...e should have the number of a personal injury atto...
Breaking Medicine News(10 mins):Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 3Health News:The Doctor Will See You Now. . .Online 2Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 3
...y and health businesses are likely to be extensive...across the world. This is expected to result in a ... a result of a global recession, //according to th...siness and health is not easy to predict. A...
...nd Children's Fund has been launched in Singapore ...for Health. The object of the fund is to help the ...th the treatment they require.// The KK Women's an... are accounted for by women, who continue to remai...
...ee as formed a new cabinet committee to plan strat...New committee has said that though the United King...b the risk of any pandemic bird flu spread but the... as there would be high shortages of disease free ...
...uman bird flu has been confirmed by China's Minist...f flu among poultry. The patient, a 35-year-old in...ember 2005 with fever and symptoms of pneumonia. ...ulture confirmed the outbreak of the disease in po...
...iation for Parenteral and Enteral Nutrition (BAPEN... over ?7.3 billion annually. This is more than twi... the Government gives a low priority to malnutriti...t any given time, the country has over 3 million p...
...estment made by the Government in treating drug ad...ith as many as 14,000 new drug users seeking treat...this figure. //This amounts to a 10% increase in t...age of heroin users is falling. About 8% of the il...
Other Medicine News:
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: